XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Both funds offer diversification; index funds are passive and typically cheaper. This comparison highlights key differences to inform your choice.
24,304 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Investors are tracing a familiar 1990 Gulf War playbook as oil climbs and energy shares outperform, while the broader...
The social security cola forecast for 2027 climbs to 3.9%, driven by persistent inflation in housing and energy. Reti...
The Nasdaq Composite climbed again as semiconductors rebound and AI-driven demand steadies, signaling a renewed risk-...
A rare volatility split signals risk concentrated in tech names. Analysts caution that this is a warning, not a crash...
Tech stocks lead a broad market pullback as AI costs rise and Netflix guidance misses, sending the Nasdaq Composite l...
The Nasdaq Composite steadied amid a breathless week of data, with investors weighing slowing growth against resilien...
Oil prices jump and stock futures wobble as Middle East tensions escalate. Traders weigh what 'iran’s supreme leader ...
Carnival and Norwegian Cruise Line surged in midweek trading, signaling a partial rebound after a brutal month for cr...
A sharp Friday selloff in tech stocks gave way to Monday gains as AI-driven names rebound, signaling that the trade’s...
After four days of tit-for-tat strikes, both sides signaled a pause in the Strait of Hormuz. Markets priced in a mana...
Retirees often rely on Social Security as a lifeline. A potential 3.8% COLA in 2027 could lift monthly checks, but th...